清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Repeat peroral endoscopic myotomy: a salvage option for persistent/recurrent symptoms

医学 肌切开术 外科 内窥镜检查 挽救疗法 普通外科 贲门失弛缓症 食管 化疗
作者
Quan‐Lin Li,Li-qing Yao,Xiaoyue Xu,Junyu Zhu,Mei-Dong Xu,Yiqun Zhang,Weifeng Chen,Ping‐Hong Zhou
出处
期刊:Endoscopy [Thieme Medical Publishers (Germany)]
卷期号:48 (02): 134-140 被引量:57
标识
DOI:10.1055/s-0034-1393095
摘要

Background and study aims: Although peroral endoscopic myotomy (POEM) is credited with high success rates in the treatment of achalasia, persistent/recurrent symptoms may occasionally develop afterwards. Our purpose was to evaluate the feasibility, safety, and efficacy of repeat peroral endoscopic myotomy (Re-POEM) as salvage therapy after initial POEM failure. Patients and methods: Fifteen patients with persistence/recurrence of symptoms after previous POEM (Eckardt symptom score ≥ 4) were retrospectively selected from a prospectively maintained database housing a total of 1454 consecutive patients with achalasia. The primary endpoint was symptom relief during follow-up, defined by an Eckardt score of ≤ 3. Secondary outcome measures were procedure-related adverse events, change in manometric lower esophageal sphincter (LES) pressure, and reflux symptoms before and after Re-POEM. Results: All patients underwent successful Re-POEM a mean of 13.5 months (range 4 – 37 months) after execution of their primary POEM procedures. Mean operative time was 41.5 minutes (range 28 – 62 minutes). One instance of submucosal tunnel infection was successfully managed with conservative treatment. During a mean follow-up period of 11.3 months (range 3 – 18 months), therapeutic success was achieved in all patients. The mean symptom score pretreatment was 5.6 (range 4 – 8), compared with a post-treatment mean of 1.2 (range 0 – 3; P < 0.001). Mean LES pressure also declined from 25.0 mmHg to 9.5 mmHg after Re-POEM (P < 0.001). The overall clinical reflux complication rate of Re-POEM was 33.3 %. Conclusions: Re-POEM appears safe and effective as a salvage option after initial POEM failure, conferring short-term symptom relief and being free of serious complications in all patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
摘星012完成签到 ,获得积分10
7秒前
李志全完成签到 ,获得积分10
10秒前
大医仁心完成签到 ,获得积分10
45秒前
1分钟前
jkaaa完成签到,获得积分10
1分钟前
pp完成签到 ,获得积分10
1分钟前
yi完成签到,获得积分10
1分钟前
1分钟前
woxinyouyou完成签到,获得积分0
1分钟前
胡可完成签到 ,获得积分10
2分钟前
yindan完成签到,获得积分10
2分钟前
2分钟前
小二郎应助yindan采纳,获得10
2分钟前
yindan给yindan的求助进行了留言
2分钟前
可爱沛蓝完成签到 ,获得积分10
2分钟前
3分钟前
王世卉完成签到,获得积分10
3分钟前
zhdjj完成签到 ,获得积分10
3分钟前
3分钟前
坚强依云发布了新的文献求助10
4分钟前
gyx完成签到 ,获得积分10
4分钟前
4分钟前
5分钟前
yindan发布了新的文献求助10
5分钟前
5分钟前
5分钟前
wildeager应助Migue采纳,获得10
6分钟前
6分钟前
6分钟前
7分钟前
鲤鱼不言完成签到 ,获得积分10
7分钟前
坦率紫菜完成签到,获得积分10
8分钟前
8分钟前
褚沛山完成签到 ,获得积分10
8分钟前
卜天亦完成签到,获得积分10
8分钟前
惜曦完成签到 ,获得积分10
8分钟前
鲤鱼不言发布了新的文献求助10
8分钟前
knight7m完成签到 ,获得积分10
9分钟前
KINGAZX完成签到 ,获得积分10
9分钟前
10分钟前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
F-35B V2.0 How to build Kitty Hawk's F-35B Version 2.0 Model 2000
Biodegradable Embolic Microspheres Market Insights 888
Quantum reference frames : from quantum information to spacetime 888
The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part III - Liver, Biliary Tract, and Pancreas (3rd Edition) 600
(The) Founding Fathers of America 500
2025-2031全球及中国蛋黄lgY抗体行业研究及十五五规划分析报告(2025-2031 Global and China Chicken lgY Antibody Industry Research and 15th Five Year Plan Analysis Report) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4458059
求助须知:如何正确求助?哪些是违规求助? 3922714
关于积分的说明 12171797
捐赠科研通 3574186
什么是DOI,文献DOI怎么找? 1963443
邀请新用户注册赠送积分活动 1002522
科研通“疑难数据库(出版商)”最低求助积分说明 897222